The Department includes Divisions dedicated to the generation of diagnostic images and to cancer therapies using ionizing radiation, which are controlled and monitored by the Health Physics Unit. IEO Radiotherapy Division is among the top 10 in the world for treatment, research and technology and thanks the recent opening of the IEO Proton Center, directly connected to the Radiotherapy Division, IEO offers the most advanced radiotherapy treatments for patients.
Numbers:
• More than 46,900 radiotherapy treatments per year
• More than 160 patients treated with Proton Therapy since the opening of the IEO Proton Center
• More than 123,700 radiodiagnostic examinations per year
• More than 14,400 Nuclear Medicine tests per year
• More than 1,400 Interventional Radiology procedures per year
The Melanoma and Sarcoma program is based on a multidisciplinary approach aimed at the diagnosis and treatment of low-incidence neoplasms, with contributions from dedicated specialists with different oncological expertise.
Specialists in Melanoma and Cutaneous Neoplasms are dedicated to prevention, early diagnosis, surgery and medical therapy at all stages of the disease, offering patients with a rare cancer the same expertise and quality of care reserved for patients with more frequent cancers.
Diseases Treated
• Melanomas
• Skin neoplasms of epithelial origin
• Sarcomas
Numbers:
• More than 700 surgical procedures per year
• More than 3,200 patients treated in the last five years
The P.U.R.E. (Prostate Urogenital Research Excellence) Program stems from the desire to create a multidisciplinary and translational approach in the management of patients with prostate cancer or other uro-oncologic diseases.
In the broader perspective of an increasingly preventive medicine aimed at the development of personalized therapies (“Tailored Therapies”), the program aims to ensure an integrated approach, minimizing the possibility of exposing patients to overdiagnosis or drug toxicities, while improving their quality of life.
Diseases Treated:
• Kidney tumors
• Bladder tumors
• Testicular tumors
• Tumours of the adrenal gland
Numbers:
• More than 1,700 surgical procedures per year
• More than 7,700 patients treated in the last five years
More than thirty professionals within the Head & Neck Division are dedicated to the diagnosis, treatment, and rehabilitation of patients with cancers of the head and neck region. The integration between the different skills enables the complex clinical issues to be addressed, from diagnosis to treatment planning to recovery of function (speech, breathing, swallowing) to achieve the best oncologic outcomes with adequate quality of life.
Diseases Treated:
• Oral cavity tumors
• Laryngeal cancers
• Cancers of the nasopharynx
• Tumors of the oropharynx
• Tumors of the hypopharynx
• Thyroid tumors
• Salivary gland tumors
• Skin and facial tumors
Numbers:
• More than 900 surgical procedures per year
• More than 3,800 patients treated in the last five years
The Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors cooperates with other three divisions (Digestive system surgery, Digestive endoscopy and Interventional radiology) to provide patients with an integrated and inter-disciplinary clinical approach that aims at the best personalization of therapeutic strategy, keeping in mind the most up-to-date national and international guidelines, and at the same time, the best opportunities for experimental treatments, according to available clinical trials.
Diseases Treated:
• Colorectal adenocarcinoma
• Biliary tract tumours
• Neuroendocrine tumours
Numbers:
• More than 2,100 surgical procedures per year
• More than 7.100 patients treated in the last five years
The most important characteristic of the Division of Gynaecology is the multidisciplinary approach through which each clinical case is treated, which particularly stands out for its synergistic work with the Senology program. Beside this linchpin, the Gynaecologic Programme excellence is represented by the definition of personalized treatments and paths of care for each patient, paths that conjugate expertise, interaction and integration between specialties, research applied to medicine, advanced surgery, studies for pre and post-surgical treatment of gynecological cancers.
Diseases Treated:
• Cervical Cancer
• Endometrial Cancer
• Ovarian Cancer
Prevention:
• Specialistic Examinations for Vulvar Pathology
• Pap test and HPV Vaccination for Cervical Pathology
• Trans-vaginal ultrasound for Endometrial Pathology
• Trans-vaginal ultrasound for Tube/Ovarian Pathology
Numbers:
• More than 1,700 surgical procedures per year
• More than 8,100 patients treated in the last five years
The Division of Onco-Haematology is dedicated to offer comprehensive treatment for all patients presenting with haematological malignancies. Each patient is treated through a multidisciplinary and personalized approach, and complete assistance is given thanks to the IEO Care 24 Service that offers care to patients during emergency.
Diseases Treated:
Hodgkin and non-Hodgkin Lymphoma, Acute Myeloid/Lymphoid Leukemia
Cell therapy: Autologous and Allogeneic Stem Cell Transplant CAR-T cell therapy
Innovative clinical trials: rare lymphoma subtypes and unmet medical needs (e.g. peripheral T-cell lymphoma, high-grade B-cell lymphoma, high-risk acute myeloid leukemia, refractory chronic myeloproliferative neoplasms)
Numbers:
• More than 300 patients treated per year
• More than 800 patients treated in the last five years
• 60 Stem cell transplant in 2023
• 25 Car-T Cell Procedures in 2023
• 35 active clinical trials
Personalized medicine is the mission of the Department of Development of New Drugs for Innovative Treatments, meaning that IEO’s specialists work to create a clinical environment where patients are treated according to their personal and tumour characteristics, in order to offer them the best therapy with the maximum benefit and the minimum toxicity.
Participating to a clinical trial represents an opportunity not only for the single patient, but for all the other patients who can benefit from the information obtained from clinical trials.
Numbers:
• 628 active clinical trials
• more than 6,300 patients involved
The team of experts of the Division of Thoracic Oncology collaborates closely to deliver individualized treatment plans that address the unique needs of each patient: ongoing research, education and compassionate clinical care are the fundamentals that allow to obtain meaningful results in the fight against lung cancer and offers hope to all those affected by this challenging disease.
Diseases Treated:
• Lung and thoracic cancers
• Tumors of the mediastinum
• Tumours of the esophagus
• Tumours of the chest wall
Numbers:
• More than 1600 surgical procedures per year.
• More than 6.900 patients treated in the last 5 years
Monzino excels in cardiovascular imaging with cutting-edge technologies like 3D echocardiography, advanced cardiac CT, and MRI. Its multimodal approach integrates AI and augmented reality for precise, low-radiation diagnostics. Renowned experts drive research and personalized care, ensuring early, accurate diagnoses and improved outcomes.
Numbers: 107,207 diagnostic exams carried out in 2023
Cardiovascular surgery at Monzino combines traditional and advanced minimally invasive techniques, addressing up to 90% of heart conditions with endoscopic methods. These procedures reduce pain, infection, recovery time, and hospital stays, while improving outcomes. Monzino is also a leading center for the Ozaki technique.
Numbers: 1,156 patients hospitalized in 2023. 971 heart surgeries and 431 vascular surgeries carried out in 2023.
Monzino is a leading center for interventional cardiovascular treatments, offering advanced diagnostic and therapeutic services for coronary artery disease, peripheral artery pathology, and structural heart conditions. With over 2,000 coronary angioplasties performed annually and cutting-edge catheterization labs, it provides comprehensive, innovative care, exceeding national standards.
Numbers: 3,819 hemodynamic procedures carried out in 2023
Ongoing Support: during the entire pathway of care, patients can rely on the support of the IEO and Monzino medical staff.
Transportation service: if your stay requires frequent shifts from and to our Hospitals, we can support you in the booking of the service.
Cultural Mediation: whenever you need language support our Hospitals can provide you with a Cultural Mediation Service available 24h and 7/7 by phone
Dedicated Clinical Staff: each clinical case is managed at a multidisciplinary level. A dedicated medical team will define the appropriate treatment pathway together with the IEO & Monzino physicians.
Dedicated Managers: during the entire Clinical Pathway you will have a single point of access, service and coordination, who will help you in the management of the administrative activities.
Pre arrival assistance: Before arriving at our Institutes you will be supported in the managing of your clinical pathway. This includes scheduling of clinical test, visits and hospitalization , invitation letter for Visa issue if needed, travel and accommodation organization.
Monzino is a leading center for treating complex heart rhythm disorders, using advanced diagnostic tools, innovative techniques, and expert electrophysiologists. Less invasive procedures are enabled by new ablation tools, miniaturized diagnostic systems, and modern implantable devices.
Numbers: 2,797 electrophysiology procedures carried out in 2023.
IEO represents a Centre of Excellence for prevention, diagnosis and treatment of breast cancer and a pioneer for all those key achievements in the field of breast surgery. The IEO Breast Cancer Team brings together the excellences of the Institute in clinical, surgical and research to achieve maximum effectiveness in serving patients. Innovation and relationship building are the linchpins that characterize the Breast Programme Team that focuses its work on the personalization of treatments while building constructive relationships with patients.
Diseases Treated:
• Breast Cancer
Numbers:
• More than 5,200 breast and plastic surgical procedures per year
• More than 24,500 in-patients in the last 5 years